Protective effects of curcumin on neonatal rats with necrotizing enterocolitis

Chinese Journal of Contemporary Pediatrics

Volumn 12, Issue 2, 2010, Pages 132-136

  Jia, Sheng Hua ^a   Wei, Hong ^a   Yu, Jia Lin ^a   Wei, Xiao Di ^a   Zhang, Xiao Ping ^a   Li, Jin Chun ^a  

^a CHILDREN S HOSPITAL OF CHONGQING MEDICAL UNIVERSITY   (China)

Author keywords

Curcumin; Cyclooxygenase 2; Necrotizing enterocolitis; Neonatal rats

Indexed keywords

CURCUMIN; CYCLOOXYGENASE 2; INTERLEUKIN 10; SOLVENT; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; HISTOPATHOLOGY; IMMUNOHISTOCHEMISTRY; NECROTIZING ENTEROCOLITIS; NEWBORN; NONHUMAN; PROTEIN EXPRESSION; RAT;

ANIMALS; ANIMALS, NEWBORN; BODY WEIGHT; CURCUMIN; CYCLOOXYGENASE 2; DISEASE MODELS, ANIMAL; ENTEROCOLITIS, NECROTIZING; FEMALE; INTERLEUKIN-10; INTESTINES; MALE; NF-KAPPA B; RATS; RATS, SPRAGUE-DAWLEY; TUMOR NECROSIS FACTOR-ALPHA;

EID: 77349099014     PISSN: 10088830     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. Buch NA, Ahmad SM, Ali SW, Hassan HM. An epidemiological study of neonatal necrotizing enterocolitis[J]. Saudi Med J, 2001, 22(3):231-237.
2. Chinese source
3. Chinese source
4. Auestad N, Korsak RA, Bergstrom JD, Edmond J. Milk-substitutes comparable to rat's milk: their preparation, composition and impact on development and metabolism in the artificially reared rat[J]. Br J Nutr, 1989, 61(3):495-518.
5. Nadler EP, Dickinson E, Knisely A, Zhang XR, Boyle P, Beer-Stolz D, et al. Expression of inducible nitric oxide synthase and interleukin-12 in experimental necrotizing enterocolitis[J]. J Surg Res, 2000, 92(1):71-77.
6. Hsuch W, Caplan MS, Qu XW, Tan XD, De Plan IG, Gonzalez-Crussi F. Neonatal necrotizing enterocolitis: clinical considerations and pathogenetic concepts[J]. Pediatr Dev Pathol, 2003, 6(1):6-23.
7. Edelson MB, Bagwell CE, Rozycki HJ. Circulating pro- and counterinflammatory cytokine levels and severity in necrotizing enterocolitis[J]. Pediatrics, 1999, 103(4):766-771.
8. Zhang M, Deng CS, Zheng JJ, Xia J. Curcumin regulated shift from Th1 to Th2 in trinitrobenzene sulphonic acid-induced chronic colitis[J]. Acta Pharmacol Sin, 2006, 27(8):1071-1077.
9. Siddiqui AM, Cui X, Wu R, Dong W, Zhou M, Hu M, et al. The anti-inflammatory effect of curcumin in an experimental model of sepsis is mediated by up-regulation of peroxisome proliferator-activated receptor-gamma[J]. Crit Care Med, 2006, 34(7):1874-1882.
10. Chinese source
11. Ramsay RG, Ciznadija D, Vanevski M, Mantamadiotis T. Transcriptional regulation of cyclo-oxygenase expression: three pillars of control[J]. Int J Immunopathol Pharmacol, 2003, 16(2 Suppl):59-67.
12. D'Halluin PN, Turlin B, Polard E, Dinasquet M, Pagenault M, Rioux N, et al. Selective COX-2 inhibitor-associated colitis: two case reports[J]. Gastroenterol Clin Biol, 2003, 27(10):932-935.
13. Chung DH, Ethridge RT, Kim S, Owens-Stovall S, Hernandez A, Kelly DR, et al. Molecular mechanisms contributing to necrotizing enterocolitis[J]. Ann Surg, 2001, 233(6):835-842.
14. Guthrie SO, Gordon PV, Thomas V, Thorp JA, Peabody J, Clark RH. Necrotizing enterocolitis among neonates in the United States[J]. J Perinatal, 2003, 23(4):278-285.
15. Jobin C, Bradham CA, Russo MP, Jurna B, Narula AS, Brenner DA, et al. Curcumin blocks cytokine-mediated NF-kappa B activation and proinflammatory gene expression by inhibiting inhibitory factor I-kappa B kinase activity[J]. J Immunol, 1999, 163(6):3474-3483.